Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00428-013-1522-1.

Title:
Testicular cancer: biology and biomarkers | Virchows Archiv
Description:
The term “human germ cell tumors” (GCTs) refers to a heterogeneous group of neoplasms, all with a defined histological appearance. They have specific epidemiological characteristics, clinical behavior, and pathogenesis. Histologically, GCTs contain various tissue elements, which are homologs of normal embryogenesis. We have proposed a subclassification of GCTs in five subtypes, three of which preferentially occur in the testis. These include teratomas and yolk sac tumors of neonates and infants (type I), seminomas and nonseminomas of (predominantly) adolescents and adults (type II), and spermatocytic seminomas of the elderly (type III). Both spontaneous and induced animal models have been reported, of which the relevance for human GCTs is still to be clarified. Multidisciplinary studies have recently shed new light on the (earliest steps in the) pathogenesis of GCTs, mainly in regard of malignant type II GCTs (germ cell cancer (GCC)). This review discusses novel understanding of the pathogenesis of (mainly) GCC, focusing on identification of informative diagnostic markers suitable for application in a clinical setting. These include OCT3/4, SOX9/FOXL2, SOX17/SOX2, as well as embryonic microRNAs. These markers have been identified through studies on normal embryogenesis, specifically related to the gonads, including the germ cell lineage. Their strengths and limitations are discussed as well as the expected future approach to identify the group of individuals at highest risk for development of a GCC. The latter would allow screening of defined populations, early diagnosis, optimal follow-up, and potentially early treatment, preventing long-term side effects of systemic treatment.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Telecommunications
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,643,078 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

pubmed, google, scholar, cas, cell, germ, testicular, cancer, central, tumors, cells, human, pathol, looijenga, expression, development, tumor, genet, tumours, risk, gene, res, study, stem, nat, int, tspy, article, testis, oct, hum, differentiation, male, dmrt, mutations, sex, mol, dev, carcinoma, protein, analysis, stoop, malignant, markers, embryonic, patients, germcell, van, clin, mouse,

Topics {✒️}

month download article/chapter hans stoop & katharina biermann testicular germ-cell tumours testicular germ-cell cancer genome-wide rnai screen gene expression-based classification c-kit protein product nordic population-based study embryonic germ cells nested case-referent study case-parent triad study ras-cyclin d2 activation high-throughput micrornaome analysis seminoma-derived nagao isozyme c-kit protein expression germ cell tumours germ cell tumors germ-cell tumors embryonal carcinoma cells germ cell tumor tspy-related sequences represent van gurp rjhlm y-chromosome gene coding human y-chromosome-derived malignant germ cells malignant germ cells genome-wide association study stem cell markers germ cell lineage stem cell factor human testicular tumors fetal germ cells gene expression profiles y-derived marker chromosome primordial germ cells c-kit receptor germ cell cancer germ-cell cancer rapid estrogen signalling foetal germ cells tumor cell lines microrna expression profiling tensin homolog regulates male gonadal differentiation shared genetic origin circulating tumor cells long-term survivors privacy choices/manage cookies messenger rna targets germ cell loss

Questions {❓}

  • Akre O, Richiardi L (2009) Does a testicular dysgenesis syndrome exist?
  • Aschim EL et al (2005) Is there an association between maternal weight and the risk of testicular cancer?
  • Belge G et al (2012) Serum levels of microRNAs miR-371-3: a novel class of serum biomarkers for testicular germ cell tumors?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Testicular cancer: biology and biomarkers
         description:The term “human germ cell tumors” (GCTs) refers to a heterogeneous group of neoplasms, all with a defined histological appearance. They have specific epidemiological characteristics, clinical behavior, and pathogenesis. Histologically, GCTs contain various tissue elements, which are homologs of normal embryogenesis. We have proposed a subclassification of GCTs in five subtypes, three of which preferentially occur in the testis. These include teratomas and yolk sac tumors of neonates and infants (type I), seminomas and nonseminomas of (predominantly) adolescents and adults (type II), and spermatocytic seminomas of the elderly (type III). Both spontaneous and induced animal models have been reported, of which the relevance for human GCTs is still to be clarified. Multidisciplinary studies have recently shed new light on the (earliest steps in the) pathogenesis of GCTs, mainly in regard of malignant type II GCTs (germ cell cancer (GCC)). This review discusses novel understanding of the pathogenesis of (mainly) GCC, focusing on identification of informative diagnostic markers suitable for application in a clinical setting. These include OCT3/4, SOX9/FOXL2, SOX17/SOX2, as well as embryonic microRNAs. These markers have been identified through studies on normal embryogenesis, specifically related to the gonads, including the germ cell lineage. Their strengths and limitations are discussed as well as the expected future approach to identify the group of individuals at highest risk for development of a GCC. The latter would allow screening of defined populations, early diagnosis, optimal follow-up, and potentially early treatment, preventing long-term side effects of systemic treatment.
         datePublished:2014-02-01T00:00:00Z
         dateModified:2014-02-01T00:00:00Z
         pageStart:301
         pageEnd:313
         sameAs:https://doi.org/10.1007/s00428-013-1522-1
         keywords:
            Germ cell tumor
            Precursor lesions
            Carcinoma in situ
            Gonadoblastoma
            Diagnostic markers
            Follow-up
            Pathology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00428-013-1522-1/MediaObjects/428_2013_1522_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00428-013-1522-1/MediaObjects/428_2013_1522_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00428-013-1522-1/MediaObjects/428_2013_1522_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00428-013-1522-1/MediaObjects/428_2013_1522_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00428-013-1522-1/MediaObjects/428_2013_1522_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00428-013-1522-1/MediaObjects/428_2013_1522_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00428-013-1522-1/MediaObjects/428_2013_1522_Fig7_HTML.gif
         isPartOf:
            name:Virchows Archiv
            issn:
               1432-2307
               0945-6317
            volumeNumber:464
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Leendert H. J. Looijenga
               affiliation:
                     name:Erasmus MC - University Medical Center Rotterdam
                     address:
                        name:Department of Pathology, Laboratory of Experimental Patho-Oncology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Hans Stoop
               affiliation:
                     name:Erasmus MC - University Medical Center Rotterdam
                     address:
                        name:Department of Pathology, Laboratory of Experimental Patho-Oncology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Katharina Biermann
               affiliation:
                     name:Erasmus MC - University Medical Center Rotterdam
                     address:
                        name:Department of Pathology, Laboratory of Experimental Patho-Oncology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Testicular cancer: biology and biomarkers
      description:The term “human germ cell tumors” (GCTs) refers to a heterogeneous group of neoplasms, all with a defined histological appearance. They have specific epidemiological characteristics, clinical behavior, and pathogenesis. Histologically, GCTs contain various tissue elements, which are homologs of normal embryogenesis. We have proposed a subclassification of GCTs in five subtypes, three of which preferentially occur in the testis. These include teratomas and yolk sac tumors of neonates and infants (type I), seminomas and nonseminomas of (predominantly) adolescents and adults (type II), and spermatocytic seminomas of the elderly (type III). Both spontaneous and induced animal models have been reported, of which the relevance for human GCTs is still to be clarified. Multidisciplinary studies have recently shed new light on the (earliest steps in the) pathogenesis of GCTs, mainly in regard of malignant type II GCTs (germ cell cancer (GCC)). This review discusses novel understanding of the pathogenesis of (mainly) GCC, focusing on identification of informative diagnostic markers suitable for application in a clinical setting. These include OCT3/4, SOX9/FOXL2, SOX17/SOX2, as well as embryonic microRNAs. These markers have been identified through studies on normal embryogenesis, specifically related to the gonads, including the germ cell lineage. Their strengths and limitations are discussed as well as the expected future approach to identify the group of individuals at highest risk for development of a GCC. The latter would allow screening of defined populations, early diagnosis, optimal follow-up, and potentially early treatment, preventing long-term side effects of systemic treatment.
      datePublished:2014-02-01T00:00:00Z
      dateModified:2014-02-01T00:00:00Z
      pageStart:301
      pageEnd:313
      sameAs:https://doi.org/10.1007/s00428-013-1522-1
      keywords:
         Germ cell tumor
         Precursor lesions
         Carcinoma in situ
         Gonadoblastoma
         Diagnostic markers
         Follow-up
         Pathology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00428-013-1522-1/MediaObjects/428_2013_1522_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00428-013-1522-1/MediaObjects/428_2013_1522_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00428-013-1522-1/MediaObjects/428_2013_1522_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00428-013-1522-1/MediaObjects/428_2013_1522_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00428-013-1522-1/MediaObjects/428_2013_1522_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00428-013-1522-1/MediaObjects/428_2013_1522_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00428-013-1522-1/MediaObjects/428_2013_1522_Fig7_HTML.gif
      isPartOf:
         name:Virchows Archiv
         issn:
            1432-2307
            0945-6317
         volumeNumber:464
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Leendert H. J. Looijenga
            affiliation:
                  name:Erasmus MC - University Medical Center Rotterdam
                  address:
                     name:Department of Pathology, Laboratory of Experimental Patho-Oncology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Hans Stoop
            affiliation:
                  name:Erasmus MC - University Medical Center Rotterdam
                  address:
                     name:Department of Pathology, Laboratory of Experimental Patho-Oncology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Katharina Biermann
            affiliation:
                  name:Erasmus MC - University Medical Center Rotterdam
                  address:
                     name:Department of Pathology, Laboratory of Experimental Patho-Oncology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Virchows Archiv
      issn:
         1432-2307
         0945-6317
      volumeNumber:464
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Erasmus MC - University Medical Center Rotterdam
      address:
         name:Department of Pathology, Laboratory of Experimental Patho-Oncology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
         type:PostalAddress
      name:Erasmus MC - University Medical Center Rotterdam
      address:
         name:Department of Pathology, Laboratory of Experimental Patho-Oncology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
         type:PostalAddress
      name:Erasmus MC - University Medical Center Rotterdam
      address:
         name:Department of Pathology, Laboratory of Experimental Patho-Oncology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Leendert H. J. Looijenga
      affiliation:
            name:Erasmus MC - University Medical Center Rotterdam
            address:
               name:Department of Pathology, Laboratory of Experimental Patho-Oncology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Hans Stoop
      affiliation:
            name:Erasmus MC - University Medical Center Rotterdam
            address:
               name:Department of Pathology, Laboratory of Experimental Patho-Oncology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Katharina Biermann
      affiliation:
            name:Erasmus MC - University Medical Center Rotterdam
            address:
               name:Department of Pathology, Laboratory of Experimental Patho-Oncology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Pathology, Laboratory of Experimental Patho-Oncology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
      name:Department of Pathology, Laboratory of Experimental Patho-Oncology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
      name:Department of Pathology, Laboratory of Experimental Patho-Oncology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(346)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

3.89s.